The Precision Medicine Initiative is “unprecedented” and represents “a turning point in medicine,” according to cardiologist Eric Topol.
In a recent interview with STAT, Topol, who serves as director of the Scripps Translational Science Institute (STSI), says the data will help to improve prevention and treatment efforts on a much more personalized level. He calls current testing “a profound waste” that proliferates “one-size-fits-all” efforts.
“This is a new day,” Topol says. “This is a reset, a reboot of what we thought about medicine, and it’s all predicated on what we know about individual people.”Read More On www.fiercehealthcare.com
Categories Precision medicine